Tower Limited (ASX:TWR) Reports Strong FY24 Full Year Results
Tower Limited (ASX:TWR) reveals strong FY24 results with significant profits, a final dividend declaration, and plans for capital return.
Tower Limited (ASX:TWR) reveals strong FY24 results with significant profits, a final dividend declaration, and plans for capital return.
Fisher & Paykel Healthcare reports record revenue and profit for 1H FY2025, with an interim dividend announcement.
Cyclopharm Limited secures purchase orders for its Technegas System from US VA hospitals, enhancing healthcare for veterans.
Emyria Limited (ASX: EMD) raises $2.525M to enhance its mental health treatment programs targeting PTSD and depression.
Dotz Nano Limited (ASX:DTZ) announces a new A$2 million investment to enhance its DotzEarth carbon capture technology development.
Cann Group Limited (ASX: CAN) secures deferral of NAB interest payments, boosting its growth strategy.
Monash IVF Group Limited (ASX:MVF) reports impressive FY24 results and maintains a positive outlook for FY25.
Delta Lithium highlights AGM outcomes, strategic focus on lithium and gold resources, and future growth plans under new Chairman Nader El Sayed.
Delta Lithium (ASX:DLI) shares AGM resolutions and operational highlights, showing strong project performance and safety track record.
Airtasker Limited (ASX:ART) highlights financial progress and strategic initiatives during its 2024 Annual General Meeting.